|
TBC1D9B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.84679999965165E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.55409999605894E-08 |
| Normal-vs-Stage2 |
1.850330E-02 |
| Normal-vs-Stage3 |
2.290600E-01 |
| Normal-vs-Stage4 |
5.718400E-01 |
| Stage1-vs-Stage2 |
5.033200E-01 |
| Stage1-vs-Stage3 |
1.560420E-01 |
| Stage1-vs-Stage4 |
3.602400E-01 |
| Stage2-vs-Stage3 |
5.030600E-01 |
| Stage2-vs-Stage4 |
5.064600E-01 |
| Stage3-vs-Stage4 |
9.077600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51740000015255E-07 |
| Normal-vs-AfricanAmerican |
2.242400E-04 |
| Normal-vs-Asian |
7.683800E-01 |
| Caucasian-vs-AfricanAmerican |
7.426800E-01 |
| Caucasian-vs-Asian |
2.850600E-01 |
| AfricanAmerican-vs-Asian |
3.402200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.08230000412024E-08 |
| Normal-vs-Female |
1.632050E-02 |
| Male-vs-Female |
9.159400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.604000E-03 |
| Normal-vs-Extreme_Weight |
2.91250000006293E-07 |
| Normal-vs-Obese |
2.958200E-04 |
| Normal-vs-Extreme_Obese |
4.414500E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.419800E-01 |
| Normal_Weight-vs-Obese |
6.891200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.028000E-01 |
| Extreme_Weight-vs-Obese |
4.105600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.484600E-01 |
| Obese-vs-Extreme_Obese |
7.383400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.781600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.339300E-03 |
| Normal-vs-Age(61-80Yrs) |
3.46210005108816E-09 |
| Normal-vs-Age(81-100Yrs) |
5.210400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.607200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.765200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.409800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.838100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.030000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.501600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.45169995416461E-10 |
| Normal-VS-Type2 PRCC |
4.655400E-01 |
| Normal-VS-KIRP CIMP |
2.02249999999848E-05 |
| Normal-VS-Unclassified PRCC |
6.161900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.45660000000036E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.735400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.380300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.704000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.176800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.021800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.882290E-03 |
| Normal-vs-N1 |
1.562190E-01 |
| Normal-vs-N2 |
9.081600E-01 |
| N0-vs-N1 |
4.521000E-01 |
| N0-vs-N2 |
2.749400E-01 |
| N1-vs-N2 |
5.091400E-01 |
|
|
